Sinocare Inc.

300298

CNE100001CJ0

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 17/01/2025			5-day change	1st Jan Change
23.63 ^CNY	+1.42%		+4.56%	-8.45%

01-08	Sinocare's Three Devices from Hunan Provincial Drug Administration	MT
12-04	Sinocare Signs Distribution Deal With Italy's Menarini Diagnostics; Shares Up 3%	MT

Sinocare Signs Distribution Deal With Italy's Menarini Diagnostics; Shares Up 3%

December 04, 2024 at 06:32 am

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Sinocare Inc.

Sinocare's Three Devices from Hunan Provincial Drug Administration	01-08	MT
Sinocare Signs Distribution Deal With Italy's Menarini Diagnostics; Shares Up 3%	12-04	MT
A. Menarini Diagnostics and Sinocare Announces Exclusive Distribution Agreement for New Continuous Glucose Monitoring System	12-03	CI
Sinocare Receives Medical Device Registration Certificates for Two Assay Kits	11-11	MT
Sinocare Q3 Profit Falls 59%, Revenue Inches Up 2%	24/10/24	MT
Sinocare Inc. Reports Earnings Results for the Nine Months Ended September 30, 2024	23/10/24	CI
Sinocare Discloses Changes in Medical Device Registration Certificates	10/09/24	MT
Sinocare Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	28/08/24	CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023.	06/08/24	CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023.	06/08/24	CI
Sinocare Inc.'s Equity Buyback announced on August 7, 2023, has closed with 3,421,500 shares, representing 0.61% for CNY 84.97 million.	05/08/24	CI
Sinocare Inc.'s Equity Buyback announced on August 7, 2023, has closed with 3,421,500 shares, representing 0.61% for CNY 84.97 million.	05/08/24	CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023.	03/07/24	CI
Sinocare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04/24	CI
Sinocare Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/04/24	CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023.	01/04/24	CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023.	03/01/24	CI
Sinocare Gets US FDA's Nod to Market Trueness Monitoring Device	06/12/23	MT
Sinocare Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/10/23	CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023.	11/10/23	CI
Sinocare Gets EU Certificate for Continuous Glucose Monitoring System	29/09/23	MT
Sinocare Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Sinocare Inc. announces an Equity Buyback for CNY 150 million worth of its shares.	07/08/23	CI
Sinocare Inc. authorizes a Buyback Plan.	06/08/23	CI
Changsha Xinnuo Health Industry Investment Co., Ltd. announced that it has received CNY 496.732672 million in funding from Sinocare Inc.	20/06/23	CI

Sinocare Inc. is a China-based company principally engaged in the research, development, production and distribution of blood sugar monitoring systems. The Company mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The Company also provides diabetes management information systems. It distributes its products within domestic market and to overseas markets under the brand name of SANNUO.

Employees

4,531

Sector

Medical Equipment, Supplies & Distribution

Calendar

16/04/2025 - Q4 2024 Earnings Release (Projected)

More about the company